GlaxoSmithKline to Acquire Tesaro for $4.16 Billion – Wall Street Journal

GlaxoSmithKline to Acquire Tesaro for $4.16 Billion – Wall Street Journal

Wall Street Journal

GlaxoSmithKline to Acquire Tesaro for $4.16 Billion
Wall Street Journal
GlaxoSmithKline GSK 1.40% PLC has agreed to buy oncology-focused pharmaceutical company Tesaro Inc. TSRO 1.33% for about $4.16 billion in cash as it looks to expand its oncology pipeline of commercially viable drugs. The British pharmaceutical …
GlaxoSmithKline to buy cancer drugmaker Tesaro for $5.1 billionLivemint


UPDATED: GSK bags Tesaro for $5B as it leaps back into commercial oncology and beefs up cancer drug pipelineEndpoints News

all 35 news articles »

171
Like
Save

Comments

Comments are disabled for this post.